Anavex Life Sciences Corp (AVXL)

[williamssc]

Frrol you make very valid points but even as late as January 11 Missling said "we look forward to advancing ANAVEX 2-73 into a larger Phase 2/3 study for Alzheimer’s". I could be all wrong here but one would have to ascertain from that statement that first patients would keep dosing as they dove tail the trial into Phase 2/3. Hopefully this will all be cleared up at the next "scientific meeting". It would have been nice if Missling would have thrown shareholder a bone though.